Список литературы

1. Anonymous International Agency for Research on Cancer. Tobacco smoking, in evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, 1996:38.

2. Anonymous International Agency for Research on Cancer. Alcohol drinking, in evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, 1998:44.

3. Trivers KF, Sabatino SA, Stewart SL (2008) Trends in esophageal cancer incidence by histology, United States, 1998 - 2003. Int J Cancer 123:1422-1428.

4. Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053.

5. Steevens J, Botterweck AAM, Dirx MJM et al (2010) Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 22:669-678.

6. Lagergren J., Bergstrom R., Lindgren A., Nyren O. "Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma." The New England Journal of Medicine, 1999; Vol 340, #11:825-831.

7. Давыдов М.И., Тер-Ованесов М.Д., Стилиди И.С. и соавт. "Пищевод Барретта: от теоретических основ к практическим рекомендациям." Практическая онкология Т. 4, N 2, 109-119, 2003.

8. Ferlay J., Shin H.R., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.//Int. J. Cancer. - Vol. 127 - 2010 - p. 2893 - 2917.

9. Miyata H, Yamasaki M, Takiguchi S, et al. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg 2011; 253:279-84.

10. Owaki T, Matsumoto M, Okumura H, et al. Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma. Am J Surg 2012; 203:191-7.

11. Eloubeidi MA, Cerfolio RJ, Bryant AS, et al. Efficacy of endoscopic ultrasound in patients with esophageal cancer predicted to have N0 disease. Eur J Cardiothorac Surg 2011; 40:636-41.

12. Chao YK, Yeh CJ, Lee MH, et al. Factors associated with false-negative endoscopic biopsy results after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma. Medicine (Baltimore) 2015; 94:e588.

13. Yen TJ, Chung CS, Wu YW, et al. Comparative study between endoscopic ultrasonography and positron emission tomographycomputed tomography in staging patients with esophageal squamous cell carcinoma. Dis Esophagus 2012; 25:40-7.

14. Molena D, Sun HH, Badr AS, et al. Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy. Dis Esophagus 2014; 27:355-9.

15. Pongpornsup S, Posri S, Totanarungroj K. Diagnostic accuracy of multidetector computed tomography (MDCT) in evaluation for mediastinal invasion of esophageal cancer. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2012; 95(5):704-11. Epub 2012/09/22. pmid:22994032.

16. Choi J, Kim SG, Kim JS, Jung HC, Song IS. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surgical endoscopy. 2010; 24(6):1380-6. Epub 2009/12/25. doi: 10.1007/s00464-009-0783-x pmid:20033712.

17. Lowe V.J., Booya F., Fletcher J.G., et al. Comparison of positron emission tomography, computed tomography and endoscopic ultrasound in the initial staging of patients with oesophageal cancer//Molecular Imaging Biol. - 2005 - Vol. 7(6) - p. 422 - 430.

18. Ding X., Zhang J., Li В., et al. A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy//Br. J. Radiol. - 2012 - Vol. 85 - p. 1019.

19. Kim TJ, Kim HY, Lee KW, Kim MS. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2009; 29:403-421.

20. Swisher SG, Maish M, Erasmus JJ, et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 2004; 78:1152-60; discussion 1152-60.

21. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus - Japan Esophageal Society - 2012.

22. Rice TW, Apperson-Hansen C, DiPaola LM et al. Worldwide Esophageal Cancer Collaboration: clinical staging data. Dis Esophagus. 2016; 7:707-14.

23. Muller J.M., Erasmi H., Stelzner M., Pichlmaier U. Surgical therapy of oesophageal carcinoma//Br. J. Surg. 1990. Vol. 77. P. 845 - 857.

24. Luketich J.D., Rivera M.A., Buenaventura P.O., et al. Minimally Invasive Esophagectomy. Outcomes in 222 Patients//Ann. Surg. - 2003 - Vol. 238(4) - p. 486 - 495

25. Matsubara Т., Veda M., Vchida C., Takahashi T. Modified Stomach Roll for safer Reconstruction After Subtotal Esophagectomy//J. Surg. Oncol. - 2000 - Vol. 74 - N 12 - p. 1115 - 1117.

26. Napier K.J., Scheerer M., Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities//World J. Gastrointest. Oncol. - 2014 - Vol. 6(5) - p. 112 - 120.

27. Gemmill E.H., McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer//Br. J. Surg. - 2007 - Vol. 94(12) - p. 1461 - 1467

28. Kim TJ, Kim HY, Lee KW, et al. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 2009; 29:403-21.

29. van Vliet EP, Heijenbrok-Kal MH, Hunink MG, et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 2008; 98:547-57.

30. Orringer M.B., Marshall В., Chang A.C., et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned//Ann Surg. - 2007 - Vol. 246(3) - p. 363 - 372.

31. O"Reilly S, Forastiere AA. Is surgery necessary with multimodality treatment of oesophageal cancer. Ann Oncol 1995; 6:519.

32. Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration. Dis Esophagus 2009; 22:1.

33. Izbicki J.R., Broering D.C., Yekebas E.F., et al. Surgery of the Esophagus. Textbook and Atlas of Surgical Practice//Steinkopff Verlag. - 2009 - 386 p.

34. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy orchemoradiotherapy for resectable oesophageal carcinoma:an updated meta-analysis. Lancet Oncol. 2011 Jul; 12(7):681-92.

35. Cunningham D, Allum WH, Stenning SP et al. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. N Engl J Med 2006; 355:11-20.

36. Ajani JA, Correa AM, Hofstetter WL, et al. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 2012; 23:2638-42.

37. P. van Hagen, M.C.C.M. Hulshof, J.J.B. van Lanschot et al. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. N Engl J Med 2012; 366:2074-84.

38. Jani J.A., Xiao L., Roth J. et al. A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Annals of Oncology 2013, 24:2844-2849.

39. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26:1086-1092.

40. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of Locally Advanced Esophageal Cancer Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01). JAMA. 1999; 281(17):1623-1627.

41. Conroy T, Galais MP, Raoul JL et al. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial. Lancet Oncol. 2014 Mar; 15(3):305-14.

42. Deng J., Wang C., Xiang M. et al. Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma//Diagnostic Pathology - 2014 - Vol. 9 - p. 151.

43. Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23:4330-7.

44. Kranzfelder M., Schuster Т., Geinitz H. et al. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer//Br. J. Surg. - 2011 - Vol. 98 - p. 768 - 783.

45. Okawa Т., Dokiya Т., Nishio M., et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group//Int. J. Radiat. Oncol. Biol. Phys. - 1999 - Vol. 45(3) - p. 623 - 628.

46. Pennathur A., Gibson M.K., Jobe B.A., Luketich J.D. Oesophageal carcinoma//Lancet - 2013 - Vol. 381 - p. 400 - 412.